Zoetis Inc. $ZTS Shares Acquired by Ethic Inc.

Ethic Inc. boosted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 56.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,000 shares of the company’s stock after buying an additional 23,204 shares during the quarter. Ethic Inc.’s holdings in Zoetis were worth $4,469,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ZTS. 180 Wealth Advisors LLC grew its holdings in Zoetis by 23.1% during the 3rd quarter. 180 Wealth Advisors LLC now owns 4,289 shares of the company’s stock worth $299,000 after acquiring an additional 805 shares during the period. Buckhead Capital Management LLC boosted its position in shares of Zoetis by 9.6% during the 3rd quarter. Buckhead Capital Management LLC now owns 44,359 shares of the company’s stock valued at $3,098,000 after purchasing an additional 3,890 shares in the last quarter. StoneX Group Inc. grew its stake in Zoetis by 7.8% during the third quarter. StoneX Group Inc. now owns 4,004 shares of the company’s stock worth $286,000 after purchasing an additional 291 shares during the period. Pictet Asset Management Holding SA grew its stake in Zoetis by 63.1% during the third quarter. Pictet Asset Management Holding SA now owns 839,570 shares of the company’s stock worth $58,627,000 after purchasing an additional 324,847 shares during the period. Finally, Privium Fund Management B.V. grew its stake in Zoetis by 36.5% during the third quarter. Privium Fund Management B.V. now owns 23,643 shares of the company’s stock worth $1,651,000 after purchasing an additional 6,321 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Stifel Nicolaus lowered their target price on Zoetis from $85.00 to $80.00 and set a “hold” rating for the company in a report on Thursday, August 20th. Citigroup reduced their price objective on shares of Zoetis from $112.00 to $96.00 and set a “buy” rating for the company in a research report on Tuesday, August 11th. Weiss Ratings upgraded shares of Zoetis from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday, October 29th. JPMorgan Chase & Co. dropped their target price on shares of Zoetis from $130.00 to $115.00 and set an “overweight” rating on the stock in a research report on Friday, August 7th. Finally, Jefferies Financial Group boosted their target price on shares of Zoetis from $83.00 to $85.00 in a research report on Friday, November 6th. Eight analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $101.25.

Zoetis Stock Performance

Shares of ZTS stock opened at $82.48 on Wednesday. The firm has a 50-day moving average of $75.88 and a 200-day moving average of $92.18. The company has a market cap of $33.51 billion, a P/E ratio of 14.03, a P/E/G ratio of 1.19 and a beta of 0.67. The company has a debt-to-equity ratio of 2.51, a current ratio of 2.35 and a quick ratio of 1.40. Zoetis Inc. has a one year low of $68.77 and a one year high of $132.49.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Thursday, November 5th. The company reported $1.75 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.24. Zoetis had a net margin of 26.15% and a return on equity of 85.90%. The business had revenue of $2.39 billion for the quarter, compared to analysts’ expectations of $2.30 billion. During the same period in the previous year, the company earned $1.70 earnings per share. The firm’s revenue for the quarter was down 1.3% compared to the same quarter last year. Equities research analysts forecast that Zoetis Inc. will post 6.29 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 1st. Investors of record on Friday, October 30th will be issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Friday, October 30th. Zoetis’s payout ratio is 36.05%.

Zoetis Profile

Zoetis is an animal health company that discovers, develops, manufactures and markets medicines, vaccines, diagnostic products and other services for animals. Its products support both companion animals, such as dogs and cats, and livestock, including cattle, pigs, poultry, sheep and fish. The company’s offerings include treatments for pain, infections and skin conditions, as well as vaccines, parasiticides, diagnostic tools and genetic testing services. Zoetis serves veterinarians, livestock producers and other animal health professionals around the world.